Screening of Candidate Oncogenes in Human Thyrotroph Tumors: Absence of Activating Mutations of the Gαq, Gα11, Gαs, or Thyrotropin-Releasing Hormone Receptor Genes

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 1134-1140

  Dong, Qihan ^a,c   Brucker Davis, Françoise ^c   Weintraub, Bruce D ^c   Smallridge, Robert C ^e   Carr, Frances E ^e   Battey, James ^d   Spiegel, Allen M ^c   Shenker, Andrew ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C; PROTIRELIN; PROTIRELIN RECEPTOR;

ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; ENDOCRINE TUMOR; FEMALE; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HORMONAL REGULATION; HUMAN; HYPOTHESIS; MALE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BASE SEQUENCE; FEMALE; GENES; GENETIC SCREENING; GTP-BINDING PROTEINS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENES; PITUITARY NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, THYROTROPIN-RELEASING HORMONE; THYROTROPIN;

EID: 0029981230     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.3.8772588     Document Type: Article

References (68)

1. s and stimulate adenylyl cyclase in human pituitary tumours. Nature. 340:692-696.
2. Spada A, Vallar L, Faglia G. 1994 Cellular alterations in pituitary tumors. Eur J Endocrinol. 130:43-52.
3. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M. 1993 Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis. Cancer. 72:1386-1393.
4. Boggild MD, Jenkinson S, Pistorello M, et al. 1994 Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab. 78:387-392.
5. Montminy M. 1993 The road not taken. Nature. 364:190-191.
6. Spada A, Arosio M, Bochicchio D, et al. 1990 Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab. 71:1421-1426.
7. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-568.
8. Gesundheit N, Petrick PA, Nissim M, et al. 1989 Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity: case reports and follow-up of nine patients. Ann Intern Med. 111:827-835.
9. Smallridge RC. 1993 Thyrotropin-secreting tumors. In: Mazzaferri EL, Samaan NA, eds. Endocrine tumors. Boston: Blackwell Scientific; 136-151.
10. 3 rat pituitary cells. J Biol Chem. 267:24983-24988.
11. 11. Mol Endocrinol. 6:1673-1681.
12. q guanine nucleotide regulatory proteins differentially modulate the response to thyrotropin-releasing hormone in Xenopus oocytes. FEBS Lett. 307:237-240.
13. 1 cells. Mol Pharmacol. 46:644-652.
14. 11 are concurrently activated by bombesin and vasopressin in Swiss 3T3 cells. FEBS Lett. 349:201-204.
15. 11 proteins in transfected Cos-7 cells. J Biol Chem. 267:1811-1817.
16. q proteins. J Biol Chem. 269:19933-19940.
17. Carr FE, Fisher CU, Fein HG, Smallridge RC. 1993 Thyrotropin-releasing hormone stimulates c-jun and c-fos messenger ribonucleic acid levels: implications for calcium mobilization and protein kinase-C activation. Endocrinology. 133:1700-1707.
18. Ohmichi M, Sawada T, Kanda Y, et al. 1994 Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. J Biol Chem. 269:3783-3788.
19. q protein induces malignant transformation in NIH 3T3 cells. Mol Cell Biol. 12:4687-4693.
20. q-α-subunits. J Biol Chem. 267:18263-18266.
21. Julius D, Livelli TJ, Jessell TM, Axel R. 1989 Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science. 244:1057-1062.
22. Gutkind JS, Novotny EA, Brann MR, Robbins KC. 1991 Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA. 88:4703-4707.
23. 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA. 88:11354-11358.
24. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 325:1688-1695 (correction in N Engl J Med. 326:1648).
25. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
26. Coughlin SR. 1994 Expanding horizons for receptors coupled to G proteins: diversity and disease. Curr Opin Cell Biol. 6:191-197.
27. Heinflink M, Nussenzveig DR, Friedman AM, Gershengorn MC. 1994 Thyrotropin-releasing hormone receptor activation does not elevate intracellular cyclic adenosine 3′,5′-monophosphate in cells expressing high levels of receptors. J Clin Endocrinol Metab. 79:650-652.
28. Kim DS, Ahn SK, Yoon JH, et al. 1994 Involvement of a cAMP-responsive DNA element in mediating TRH responsiveness of the human thyrotropin a-subunit gene. Mol Endocrinol. 8:528-536.
29. Brucker-Davis F, Dong Q, Oldfield EH, Spiegel AM, Shenker A, Weintraub BD. Clinical and oncogenic study of 21 patients with TSH-secreting pituitary tumors (TT) followed at the NIH: assessment of thyroid hormone (TH) action and treatment outcome. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 47.
30. q gene (GNAQ) and a processed pseudogene. Genomics. 30:470-475.
31. Jiang M, Pandey S, Tran VT, Fong HK. 1991 Guanine nucleotide-binding regulatory proteins in retinal pigment epithelial cells. Proc Natl Acad Sci USA. 88:3907-3911.
32. qα. Mutational activation and coupling to receptors and phospholipase C. J Biol Chem. 267:31-34.
33. Duthie SM, Taylor PL, Anderson L, Cook J, Eidne KA. 1993 Cloning and functional characterisation of the human TRH receptor. Mol Cell Endocrinol. 95:R11-R15.
34. Matre V, Karlsen HE, Wright MS, et al. 1993 Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem Biophys Res Commun. 195:179-185.
35. Yamada M, Monden T, Satoh T, et al. 1993 Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene. Biochem Biophys Res Commun. 195:737-745.
36. Lerman LS, Silverstein K. 1987 Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol. 155:482-501.
37. Higuchi R. 1990 Recombinant PCR. In: Innis MA, Gelfand DH, Snisky JJ, White TJ, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press; 177-183.
38. Grompe M. 1993 The rapid detection of unknown mutations in nucleic acids. Nature Genet. 5:111-117.
39. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol. 8:334-339.
40. Kosugi S, Van Dop C, Geffner ME, et al. 1995 Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet. 4:183-188.
41. Matus-Leibovitch N, Nussenzveig DR, Gershengorn MC, Oron Y. 1995 Truncation of the thyrotropin-releasing hormone receptor carboxyl tail causes constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells. J Biol Chem. 270:1041-1047.
42. 2+ in human adenomatous lactotrophs. J Endocrinol Invest. 13:13-18.
43. Bevan JS, Burke CW, Esiri MM, et al. 1989 Studies of two thyrotropin-secreting pituitary adenomas: evidence for dopamine receptor deficiency. Clin Endocrinol (Oxf). 31:59-70.
44. Levy A, Eckland DJA, Gurney AM, Reubi J-C, Doshi R, Lightman SL. 1989 Somatostatin and thyrotropin-releasing hormone response and receptor status of a thyrotropin-secreting pituitary adenoma: clinical and in vitro studies. J Neuroendocrinol. 1:321-326.
45. Chanson P, Li JY, Le Dafniet M, et al. 1988 Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism. J Clin Endocrinol Metab. 66:447-450.
46. 4 pituitary cell proliferation by blocking entry into S phase. Endocrinology. 126:472-479.
47. Seuwen K, Pouysségur J. 1992 G protein-controlled signal transduction pathways and the regulation of cell proliferation. Adv Cancer Res. 58:75-94.
48. Stephens EV, Kalinec G, Brann MR, Gutkind JS. 1993 Transforming G protein-coupled receptors transduce potent mitogenic signals in NIH 3T3 cells independent on CAMP inhibition or conventional protein kinase C. Oncogene. 8:19-26.
49. Alvaro V, Levy L, Dubray C, et al. 1993 Invasive human pituitary tumors express a point-mutated α-protein kinase-C. J Clin Endocrinol Metab. 77:1125-1129.
50. Borner C, Filipuzzi I, Weinstein IB, Imber R. 1991 Failure of wild-typo or a mutant form of protein kinase C-α to transform fibroblasts. Nature. 353:78-80.
51. 1B α subunit defines a novel family of oncogenes. Biochem Biophys Res Commun. 201:603-609.
52. q-α potentiates platelet-derived growth factor-stimulated mitogenesis in confluent cell cultures. J Biol Chem. 269:19671-19674.
53. Paulssen RH, Paulssen EJ, Gautvik KM, Gordeladze JO. 1992 The thyroliberin receptor interacts directly with a stimulatory guanine-nucleotide-binding protein in the activation of adenylyl cyclase in GH, rat pituitary tumour cells. Evidence obtained by the use of antisense RNA inhibition and immunoblocking of the stimulatory guanine-nucleotide-binding protein. Eur J Biochem. 204:413-418.
54. s couples thyrotropin-releasing hormone receptors expressed in Xenopus oocytes to phospholipase C. J Biol Chem. 270:3554-3559.
55. Danon M, Crawford JD. 1987 The McCune-Albright syndrome. Ergeb Inn Med Kinderheilkd. 55:81-115.
56. Sd, protein. J Clin Endocrinol Metab. 79: 1128-1134.
57. Friedman E, Adams EF, Hoog A, et al. 1994 Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. J Clin Endocrinol Metab. 78:568-574.
58. Cai WY, Alexander JM, Hedley-Whyte ET, et al. 1994 Ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab. 78:89-93.
59. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM. 1994 Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab. 78:922-927.
60. Pellegríni I, Barlier A, Gunz G, et al. 1994 Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab. 79:189-196.
61. Woloschak M, Roberts JL, Post K. 1994 c-myc, c-fos, and c-myb gene expression in human pituitary adenomas. J Clin Endocrinol Metab. 79:253-257.
62. 3 cells. Proc Natl Acad Sci USA. 90:6265-6269.
63. 2+ spike and oscillations induced by different doses of thyrotropin-releasing hormone (TRH) in individual pituitary cells and nonexcitable cells transfected with TRH receptor complementary deoxyribonucleic acid. Endocrinology. 135:1084-1092.
64. Chanson P, Orgiazzi J, Derome PJ, et al. 1984 Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab. 59:542-546.
65. Brucker-Davis F, Skarulis MC, Grace MB, et al. 1995 Genetic and clinical features of 42 kindreds with resistance to thyroid hormone: the NIH prospective study. Ann Intern Med. 123:572-583.
66. Samaan NA, Osborne BM, Mackay B, Leavens ME, Duello TM, Halmi NS. 1977 Endocrine and morphological studies of pituitary adenomas secondary to primary hypothyroidism. J Clin Endocrinol Metab. 45:903-911.
67. Yamamoto K, Saito K, Takai T, Naito M, Yoshida S. 1983 Visual field defects and pituitary enlargement in primary hypothyroidism. J Clin Endocrinol Metab. 57:283-287.
68. Watanabe K, Kameya T, Yamauchi A, et al. 1993 Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab. 76:1025-1030.